Related Experiment Videos
Prolonged mivacurium neuromuscular block in children
C Lejus1, Y Blanloeil, N Le Roux
1Service d'Anesthésie et de Réanimation Chirurgicale, CHR Nantes, France.
Paediatric Anaesthesia
|September 22, 1998
Summary
Two children experienced prolonged neuromuscular block from mivacurium due to undiagnosed plasma cholinesterase deficiency. Genetic testing revealed a homozygous atypical genotype, impacting anesthetic management and family screening.
Area of Science:
- Anesthesiology
- Clinical Pharmacology
- Human Genetics
Background:
- Neuromuscular blocking agents like mivacurium are commonly used in pediatric anesthesia.
- Plasma cholinesterase deficiency can prolong the effects of certain neuromuscular blockers.
- Genetic variations, such as atypical genotypes, are known causes of enzyme deficiencies.
Observation:
- Two pediatric cases presented with unexpectedly prolonged neuromuscular block post-mivacurium administration.
- These children had undiagnosed plasma cholinesterase deficiency.
- The deficiency was linked to a homozygous atypical genotype.
Findings:
- Detailed anesthetic management strategies were employed for these patients.
- Phenotypic determination was performed for the affected children.
- Family members were also screened to identify other carriers of the genetic deficiency.
Implications:
- Highlights the importance of recognizing and diagnosing plasma cholinesterase deficiency in pediatric patients.
- Informs anesthetic protocols for patients with known or suspected enzyme deficiencies.
- Emphasizes the utility of genetic and phenotypic analysis in managing adverse drug reactions.